Các bài nghiên cứu mới về COVID-19 từ ngày 16/04 đến ngày 23/04/2021

Cập nhật vào: Thứ tư - 21/04/2021 19:38 Cỡ chữ Nhỏ Lớn

Cục Thông tin KH&CN quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 16/04 đến ngày 23/04/2021. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.

SCIENCEDIRECT

1. Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019

Clinica Chimica Acta, 22 February 2021, Volume 517 (Cover date: June 2021), Pages 48-53

Ding-Hui Peng, Yi Luo, Wei Chen

https://www.sciencedirect.com/science/article/pii/S000989812100053X/pdfft?md5=3ef86870317ceb3ea74dbcc61dc7d490&pid=1-s2.0-S000989812100053X-main.pdf

2. Combined recombinase polymerase amplification/rkDNA–graphene oxide probing system for detection of SARS-CoV-2

Analytica Chimica Acta, 19 March 2021, Volume 1158 (Cover date: 8 May 2021), Article 338390

Moon Hyeok Choi, Jaehyeon Lee, Young Jun Seo

https://www.sciencedirect.com/science/article/pii/S0003267021002166/pdfft?md5=2e0135a89f63dc41066edc105f52e863&pid=1-s2.0-S0003267021002166-main.pdf

3. Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery

Journal of Molecular Structure, 26 March 2021, Volume 1237 (Cover date: 5 August 2021), Article 130366

Kalyan Ghosh, Sk. Abdul Amin, Tarun Jha

https://www.sciencedirect.com/science/article/pii/S0022286021004993/pdfft?md5=35fb4f4ae4fa368ef6066f5b58fcbed1&pid=1-s2.0-S0022286021004993-main.pdf

4. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome

Journal of Allergy and Clinical Immunology, 9 February 2021, Volume 147, Issue 4 (Cover date: April 2021), Pages 1226-1233.e2

Christian Rosas-Salazar, Kyle S. Kimura, Suman R. Das

https://www.sciencedirect.com/science/article/pii/S0091674921001779/pdfft?md5=70bc598c94c0654c211a483068950be3&pid=1-s2.0-S0091674921001779-main.pdf

5. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19

Heliyon, 28 January 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e06133

Fahd Al-Mulla, Anwar Mohammad, Thangavel Alphonse Thanaraj

https://www.sciencedirect.com/science/article/pii/S2405844021002383/pdfft?md5=0bbf48aaced52c9cd5e11c3768356129&pid=1-s2.0-S2405844021002383-main.pdf

6. Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate

Biochimica et Biophysica Acta (BBA) - General Subjects, 14 March 2021, Volume 1865, Issue 6 (Cover date: June 2021), Article 129893

Wen-Hsiang Chen, Junfei Wei, Maria Elena Bottazzi

https://www.sciencedirect.com/science/article/pii/S0304416521000519/pdfft?md5=b6a35cfb1cb9e4256a63305df5c4ba35&pid=1-s2.0-S0304416521000519-main.pdf

7. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway

iScience, 9 March 2021, Volume 24, Issue 4 (Cover date: 23 April 2021), Article 102293

Xiaoyuan Lin, Beibei Fu, Haibo Wu

https://www.sciencedirect.com/science/article/pii/S2589004221002613/pdfft?md5=5f15b7895de6485df52a32adcf79cc3a&pid=1-s2.0-S2589004221002613-main.pdf

8. Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection

Journal of Lipid Research, 2 March 2021, Volume 62 (Cover date: 2021), Article 100061

James R. Hilser, Yi Han, Hooman Allayee

https://www.sciencedirect.com/science/article/pii/S0022227521000432/pdfft?md5=7179335eb03cddebe2a8610319d65bce&pid=1-s2.0-S0022227521000432-main.pdf

9. Tricuspid annular plane systolic excursion (TAPSE) measured by echocardiography and mortality in COVID-19: A systematic review and meta-analysis

International Journal of Infectious Diseases, 11 February 2021, Volume 105 (Cover date: April 2021), Pages 351-356

Januar Wibawa Martha, Raymond Pranata, Michael Anthonius Lim

https://www.sciencedirect.com/science/article/pii/S1201971221001156/pdfft?md5=21851bf1e33b4efc1f3bc71944e31f38&pid=1-s2.0-S1201971221001156-main.pdf

10. Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis

Chemico-Biological Interactions, 18 February 2021, Volume 338 (Cover date: 1 April 2021), Article 109420

Yajing Hou, Shuai Ge, Langchong He

https://www.sciencedirect.com/science/article/pii/S0009279721000569/pdfft?md5=a206d7ce9233164962a3671953b37b64&pid=1-s2.0-S0009279721000569-main.pdf

11. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.

EBioMedicine, 2 April 2021, Volume 66 (Cover date: April 2021), Article 103317

Aishwarya Venkataraman, Nathella Pavan Kumar, Subash Babu

https://www.sciencedirect.com/science/article/pii/S2352396421001109/pdfft?md5=9fed96ef86925307edcb6b6aacf2cc0f&pid=1-s2.0-S2352396421001109-main.pdf

12. The incidence of pleural effusion in COVID-19 pneumonia: State-of-the-art review

Heart & Lung, 27 February 2021, Volume 50, Issue 4 (Cover date: July–August 2021),Pages 481-490

Woon H. Chong, Biplab K. Saha, Amit Chopra

https://www.sciencedirect.com/science/article/pii/S0147956321000522/pdfft?md5=2e5c0ab3789b04b35c9b64dfebb4d47d&pid=1-s2.0-S0147956321000522-main.pdf

13. Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series

Multiple Sclerosis and Related Disorders, 13 March 2021, Volume 51 (Cover date: June 2021), Article 102900

Nurhan Kaya Tutar, Sami Omerhoca, Nilufer Kale

https://www.sciencedirect.com/science/article/pii/S221103482100167X/pdfft?md5=27347de64ff6e05021f59ccd3eb73781&pid=1-s2.0-S221103482100167X-main.pdf

14. Forensic evaluation of two nucleic acid extraction systems and validation of a RT-qPCR protocol for identification of SARS-CoV-2 in post-mortem nasopharyngeal swabs

Forensic Science International, 2 April 2021m Volume 323 (Cover date: June 2021)m Article 110775

Pedro A. Barrio, Amparo Fernández-Rodríguez, Antonio Alonso

https://www.sciencedirect.com/science/article/pii/S0379073821000955/pdfft?md5=e7ae8811c06b89ba3a42d25a948b1327&pid=1-s2.0-S0379073821000955-main.pdf

15. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India

Virology, 5 March 2021, Volume 558 (Cover date: June 2021), Pages 13-21

Kaustuv Nayak, Kamalvishnu Gottimukkala, Anmol Chandele

https://www.sciencedirect.com/science/article/pii/S0042682221000362/pdfft?md5=ebbc1b9bd063eed02f11ab5485f107b4&pid=1-s2.0-S0042682221000362-main.pdf

16. A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19

Journal of Infection and Chemotherapy, 19 February 2021, Volume 27, Issue 6 (Cover date: June 2021), Pages 876-881

Wei-Jing Gong, Tao Zhou, Xue-Feng Cai

https://www.sciencedirect.com/science/article/pii/S1341321X21000581/pdfft?md5=4696eae29cdcb71818450ee15c3dbbb2&pid=1-s2.0-S1341321X21000581-main.pdf

17. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Cell, 2 February 2021, Volume 184, Issue 5 (Cover date: 4 March 2021), Pages 1201-1213.e14

Aurélien Sokal, Pascal Chappert, Matthieu Mahévas

https://www.sciencedirect.com/science/article/pii/S0092867421000933/pdfft?md5=7a78e7cc53c26036e43ae676756b65a7&pid=1-s2.0-S0092867421000933-main.pdf

18. Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2

International Journal of Biological Macromolecules, 4 February 2021, Volume 176 (Cover date: 15 April 2021), Pages 1-12

Ashuai Du, Rong Zheng, Zanxian Xia

https://www.sciencedirect.com/science/article/pii/S0141813021002804/pdfft?md5=2e0f812693f83685cc35080667c3c5a5&pid=1-s2.0-S0141813021002804-main.pdf

19. Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients

Cell Reports, 12 March 2021, Volume 34, Issue 13 (Cover date: 30 March 2021), Article 108915

Yang Li, Ming-liang Ma, Sheng-ce Tao

https://www.sciencedirect.com/science/article/pii/S2211124721002291/pdfft?md5=210219517fbb8ab65297968c10c66803&pid=1-s2.0-S2211124721002291-main.pdf

20. Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment

Biomedicine & Pharmacotherapy, 8 April 2021, Volume 139 (Cover date: July 2021), Article 111586

Jing Qian, Hangdi Xu, Xiaohui Fan

https://www.sciencedirect.com/science/article/pii/S0753332221003711/pdfft?md5=cf167e9de79f35358e27107573dbe72d&pid=1-s2.0-S0753332221003711-main.pdf

21. Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients?

Medical Hypotheses, 25 March 2021, Volume 151 (Cover date: June 2021), Article 110570

Selma Rivas-Fuentes, Víctor Julián Valdés, Alfonso Salgado-Aguayo

https://www.sciencedirect.com/science/article/pii/S0306987721000888/pdfft?md5=101c312977ad9945a0ff03eba09808a9&pid=1-s2.0-S0306987721000888-main.pdf

WILEY:

1. Short‐term impact of nursing home SARS‐CoV‐2 vaccinations on new infections, hospitalizations, and deaths

Vincent Mor PhD, Roee Gutman PhD, Xiaofei Yang ScM, Elizabeth M. White APRN, PhD Kevin W. McConeghy PharmD, MS Richard A. Feifer MD, MPH Carolyn R. Blackman MD Cyrus M. Kosar MS Barbara H. Bardenheier PhD Stefan A. Gravenstein MD, MPH

Journal of the American Geriatrics Society

First published: 16 April 2021

https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.17176

2. Can ketone bodies inactivate coronavirus spike protein? The potential of biocidal agents against SARS‐CoV‐2

Alaa Shaheen

BioEssays

First published: 15 April 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1002/bies.202000312

3. Impact of cancer history on outcomes among hospitalized COVID‐19 patients

Isaac A. Klein MD, PhD Shoshana M. Rosenberg ScD, MPH Kerry L. Reynolds MD Leyre Zubiri MD, PhD Rachel Rosovsky MD Andrew J. Piper‐Vallillo MD Xin Gao MD Genevieve Boland MD, PhD Aditya Bardia MBBS, MPH Rachel Gaither BS Hannah Freeman BA Gregory J. Kirkner MPH Chanu Rhee MD, MPH Michael Klompas MD Meghan A. Baker MD, ScD Martha Wadleigh MD Eric P. Winer MD Camille N. Kotton MD Ann H. Partridge MD, MPH

The Oncologist

First published: 15 April 2021

https://theoncologist.onlinelibrary.wiley.com/doi/epdf/10.1002/onco.13794

4. Diabetic ketoacidosis drives COVID‐19 related hospitalizations in children with type 1 diabetes

G. Todd Alonso, Osagie Ebekozien, Mary Pat Gallagher, Saketh Rompicherla, Sarah K. Lyons Abha Choudhary, Shideh Majidi, Catherina T. Pinnaro, Sadana Balachandar, Mariam Gangat, Alissa Jeanne Curda ,Roberts Brynn E. Marks, Ana Creo, Janine Sanchez, Tossaporn Seeherunvong, Jose Jimenez‐Vega, Neha S. Patel, Jamie R. Wood Liana Gabriel, Kathryn M. Sumpte,r Meredith Wilkes, Robert Rapaport, Anna Cymbaluk ,Jenise C. Wong, Srinath Sanda, Anastasia Albanese‐O'neill

Journal of Diabetes